In late 2022 tilapia parvovirus (TiPV) was found to be associated with mass mortalities of tilapia in Odisha, India, both individually and in co-infections with tilapia lake virus. Infections have also been reported from Thailand and China.

Clinical signs include lethargy, scale loss, redness on the body with haemorrhages on the operculum, base of fins and ventral part, opaqueness of the eyes, swimming near the pond edge and loss of appetite before death.

This article describes the epidemiology of TiPV disease including its diagnosis, transmission, prevention and control, and its potential impact on the tilapia aquaculture industry.